Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) EPS (Basic): 2011-2024

Historic EPS (Basic) for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $0.11.

  • Niagen Bioscience's EPS (Basic) rose 200.00% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.27, marking a year-over-year increase of 2285.39%. This contributed to the annual value of $0.11 for FY2024, which is 257.14% up from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's EPS (Basic) is $0.11, which was up 257.14% from -$0.07 recorded in FY2023.
  • Niagen Bioscience's 5-year EPS (Basic) high stood at $0.11 for FY2024, and its period low was -$0.40 during FY2021.
  • Its 3-year average for EPS (Basic) is -$0.07, with a median of -$0.07 in 2023.
  • Its EPS (Basic) has fluctuated over the past 5 years, first decreased by 21.21% in 2021, then soared by 257.14% in 2024.
  • Yearly analysis of 5 years shows Niagen Bioscience's EPS (Basic) stood at -$0.33 in 2020, then decreased by 21.21% to -$0.40 in 2021, then skyrocketed by 40.00% to -$0.24 in 2022, then skyrocketed by 70.83% to -$0.07 in 2023, then soared by 257.14% to $0.11 in 2024.